Shanghai Haohai Biological Tech Co Cash Flow Conversion Efficiency
Shanghai Haohai Biological Tech Co cash flow conversion efficiency. Based on the latest financial reports, Shanghai Haohai Biological Tech Co (688366) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.13 Million ≈ $15.97 Million USD) by net assets (CN¥5.88 Billion ≈ $861.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shanghai Haohai Biological Tech Co (2012–2024)
Cash flow conversion efficiency of Shanghai Haohai Biological Tech Co from 2012 to 2024. This chart illustrates how Shanghai Haohai Biological Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688366 stock price and chart for real-time trading data and today's change.
Shanghai Haohai Biological Tech Co Cash Flow Conversion Ratio Explained
Shanghai Haohai Biological Tech Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shanghai Haohai Biological Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haohai Biological Tech Co ranked by their cash flow conversion efficiency. Also see market value of Shanghai Haohai Biological Tech Co for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Latigo Biotherapeutics, Inc. Common Stock
NASDAQ:LTGO
|
0.077x |
|
Galaxy Surfactants Limited
NSE:GALAXYSURF
|
0.067x |
|
SUFA Technology Industry Co Ltd CNNC
SHE:000777
|
0.002x |
|
Changzhou Youon Pubilic Bicycle System Co Ltd
SHG:603776
|
0.022x |
|
Jiangsu Sanfangxiang Industry Co Ltd
SHG:600370
|
0.168x |
|
D-MARKET E.S.+T.SP.ADR/1B
F:8WZ
|
-3.858x |
|
Abacus Global Management, Inc.
NYSE:ABX
|
0.089x |
|
KEDE Numerical Control Co Ltd
SHG:688305
|
0.028x |
Annual Cash Flow Conversion Efficiency for Shanghai Haohai Biological Tech Co (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Haohai Biological Tech Co from 2012 to 2024. Review free cash flow generation of Shanghai Haohai Biological Tech Co to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.92 Billion ≈ $865.85 Million |
CN¥648.57 Million ≈ $94.91 Million |
0.110x | +3.96% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.52 Million |
CN¥634.45 Million ≈ $92.84 Million |
0.105x | +169.06% |
| 2022-12-31 | CN¥5.90 Billion ≈ $863.70 Million |
CN¥231.30 Million ≈ $33.85 Million |
0.039x | -30.62% |
| 2021-12-31 | CN¥6.06 Billion ≈ $886.81 Million |
CN¥342.29 Million ≈ $50.09 Million |
0.056x | +23.58% |
| 2020-12-31 | CN¥5.73 Billion ≈ $839.10 Million |
CN¥262.07 Million ≈ $38.35 Million |
0.046x | -25.95% |
| 2019-12-31 | CN¥5.65 Billion ≈ $827.26 Million |
CN¥348.91 Million ≈ $51.06 Million |
0.062x | -39.50% |
| 2018-12-31 | CN¥3.84 Billion ≈ $561.25 Million |
CN¥391.28 Million ≈ $57.26 Million |
0.102x | +0.12% |
| 2017-12-31 | CN¥3.37 Billion ≈ $492.65 Million |
CN¥343.06 Million ≈ $50.20 Million |
0.102x | +19.56% |
| 2016-12-31 | CN¥2.99 Billion ≈ $436.93 Million |
CN¥254.49 Million ≈ $37.24 Million |
0.085x | -15.39% |
| 2015-12-31 | CN¥2.67 Billion ≈ $390.04 Million |
CN¥268.51 Million ≈ $39.29 Million |
0.101x | -57.85% |
| 2014-12-31 | CN¥594.16 Million ≈ $86.94 Million |
CN¥141.99 Million ≈ $20.78 Million |
0.239x | -11.33% |
| 2013-12-31 | CN¥545.05 Million ≈ $79.76 Million |
CN¥146.91 Million ≈ $21.50 Million |
0.270x | -10.48% |
| 2012-12-31 | CN¥393.33 Million ≈ $57.56 Million |
CN¥118.42 Million ≈ $17.33 Million |
0.301x | -- |
About Shanghai Haohai Biological Tech Co
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more